Skip to main content

Enhancing biological drug production through protein secretion

Obiettivo

Biotherapeutics are bio-materials, which are used among others to treat cancer, diabetes, and rare diseases. It is expected that these medicines will make up half of the medicines in future. Already now, 350 million patients are treated with biotherapeutics, produced from proteins. The proteins that are injected to humans must be “clean” and pure. However, harvesting a protein from cells and purifying it is a daunting challenge. Current harvesting methods are complicated and expensive.
We made a discovery, which would significantly improve the harvesting and purification process, therefore lowering drug production costs. In this process, biological cells are producing desired proteins from a gene that was planted into the cell’s genome. The key is that after the protein has been produced within cells, we will then induce the cells to send the protein outside – to the liquid medium. This makes the harvesting and purification process much more efficient. The innovation lies in encoding the protein with RNA-based tag. When attached to a gene of interest, the tag will make the producing cell secrete the encoded protein to the medium.
If we program proteins to be secreted to the extracellular medium more efficiently protein harvesting and purification process in Pharma, Biotech and Agricultural industries could be revolutionized. This is extremely important for the Pharma industry, which is struggling on low return on investment, already threatening the sector’s viability. Quicker drug development process, cheaper and higher quality production and improved ROI will create also societal benefit. In the end, new drugs can be discovered and brought to markets quicker.
In the PoC, we will characterize and discover the best tags for protein production and secretion and use it to secret key drugs essential for the Pharma industry, and demonstrate the feasibility of our technology and carry out pre-commercialization actions in order to shorten our innovation’s time to market.

Invito a presentare proposte

ERC-2018-PoC
Vedi altri progetti per questo bando

Meccanismo di finanziamento

ERC-POC - Proof of Concept Grant

Istituzione ospitante

WEIZMANN INSTITUTE OF SCIENCE
Indirizzo
Herzl Street 234
7610001 Rehovot
Israele
Tipo di attività
Higher or Secondary Education Establishments
Contributo UE
€ 150 000

Beneficiari (1)

WEIZMANN INSTITUTE OF SCIENCE
Israele
Contributo UE
€ 150 000
Indirizzo
Herzl Street 234
7610001 Rehovot
Tipo di attività
Higher or Secondary Education Establishments